Research Projects & Grants

For Profit Organization

  • Effectiveness of semaglutide 2.4 mg vs. commercially available medications for chronic weight management in participants with obesity in a multi-employer setting in the US – a pragmatic clinical study (POSEY), Role: Investigator, Novo Nordisk Pharmaceuticals Inc., (10/2022) Status: Approved

Internal

  • Transcriptomics of Pharmaceutically Assisted Lifestyle Management of Obesity Study (Ts)”, Role: PI, LLU School of Public Health, (06/2023) Status: Approved